EVALUATION OF COMPRESSION PROCESS VARIABLES FOR MULTIUNIT PARTICULATE SYSTEM (MUPS) TABLET BY QbD APPROACH
Journal Title: Journal of Drug Delivery and Therapeutics - Year 2018, Vol 8, Issue 1
Abstract
Objective: The objective of the study was to evaluate and optimize compression process variables of Esomeprazole (Multiunit particulate system) MUPS tablet. Materials and methods: A three-factor, two-level, full factorial design was used to investigate the influence process variables Viz. Main compression force, Pre-compression force and Turret speed. Responses studied were Weight variation, Hardness, Thickness, Friability, Content uniformity, Drug release in 0.1N HCl at 120min and drug release in pH 6.5 simulated intestinal fluid at 15 min. Results and discussion: Main compression force and the Pre-compression force had a significant influence on hardness, thickness, drug release in 0.1N HCl at 120min and drug release in pH 6.5 SIF at 15min. Higher compression force leads to breakage of pellets during compression which showed impact drug release at acid stage. Turret speed had significant impact on final weight variation and content uniformity. The optimized process parameters Main compression force: 11.33 kP, Pre-compression force: 2.72 Kp and Turret speed: 23.56 rpm showed desired physical characteristics and drug release in 0.1N HCl which will result in lesser degradation of API at acid stage. Conclusion: It is concluded that Compression process variables in preparation of Esomeprazole MUPS were successfully evaluated using Design of Experiment approach. Keywords: process variables, Esomeprazole, Multiunit particulate system
SURGERY CAN BE AVOIDED IN EXTRA OCULAR AND ORBITAL MYOCYSTICERCOSIS
Aim: To study the efficacy of Albendazole in treating Extra ocular and Orbital Myocysticercosis. Materials and Methods: This is a prospective interventional case study conducted at Department of Oculoplasty and Orbita...
A NOVEL CLASS OF PHOTOTRIGGERABLE LIPOSOMES CONTAINING PACLITAXEL FOR THE TREATMENT OF SKIN CANCER
Success of nanocarriers-mediated drug delivery solely depends on delivery of therapeutics to a specified target. Secondly therapeutically active amount of drug should be released within defined space and time (triggered...
ESTROGEN ANCHORED NANOMICELLES FOR COMBINATIONAL DRUG DELIVERY WITH ENHANCED THERAPEUTIC EFFICACY: A PROTEOMICS GUIDED INVESTIGATION FOR MULTIFUNCTIONAL NANOTHERAPEUTICS
The employment of the stable isotope labeling with amino acids in cell culture (SILAC) based proteomic analysis as a guidance tool for investigation of cellular response of a multifunctional nanodelivery system has been...
BOTOX! BETTER OPTION TO PROTECT CORNEA IN IDIOPATHIC BELL’S PALSY
Aim: Is to evaluate the efficacy of Chemo-denervation of LPS to induce temporary ptosis using Injection Botox in protecting Cornea and healing exposure keratopathy.
ELUCIDATING THE STRUCTURAL REQUIREMENTS OF NOVEL PAZOPANIB DERIVATIVES TOWARDS TYROSINE KINASE INHIBITORY ACTIVITY THROUGH CLASSICAL HANSCH AND DE-NOVO APPROACH
Quantitative structure–activity relationship (QSAR) and Molecular modeling study have been performed on a series of novel Pazopanib derivatives by using the Mixed Hansch Fujita-Ban approach and employing AM1 calculations...